Biomarker predicts breast cancer recurrence

Those who survive breast cancer still live under the uneasy threat of recurrence. But a recent biomarker discovery might take the mystery and guesswork out of that threat. Researchers from Virginia Commonwealth University Massey Cancer Center have discovered a new biomarker related to the body's immune system that can predict breast cancer patients' risk of recurrence. The researchers found that a specific, five-gene signature related to tumor infiltrating immune cells can accurately predict relapse-free survival. The signature predicted relapse with more than 85 percent accuracy. Release | UPI story

Suggested Articles

IBM and Pfizer developed an artificial intelligence model that could eventually predict if a person will develop Alzheimer’s using a language test.

Becton, Dickinson and Company is moving up two of its senior staffers into major roles for the medtech company as its CTO retires.

There are many companies losing out over the economic impact of the pandemic, but Quest Diagnostics is one that is booming as a result.